Episodes

  • Trial of the Week: ROSE

    Trial of the Week: ROSE
    Jul 10 2024
    Trial of the Week: ROSE Special Guest: Christina Rose, PharmD, BCCCP, FCCM @CRosePharmD 05:40 – Pathophysiology/ACURASYS trial 13:45 – ROSE trial discussion 38:40 – Current role of NMBA in ARDS Reference list: https://pharmacytodose.com/wp-content/uploads/2024/07/rose-tow-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    54 mins
  • HRS-AKI & Terlipressin

    HRS-AKI & Terlipressin
    Jul 5 2024
    HRS-AKI & Terlipressin Special Guest: Stephanie Bass, PharmD, FCCP, BCPS, BCCCP 05:45 – HRS and HRS-AKI diagnosis 17:00 – Albumin and volume status 23:55 – Terlipressin/vasoconstrictor treatment 52:00 – Medication safety considerations Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/hrsaki-terlipressin-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    1 hr and 4 mins
  • Rapid Reaction: BLING III

    Rapid Reaction: BLING III
    Jul 3 2024
    Rapid Reaction: BLING III Special Guest: Jason Roberts, BPharm, PhD, FSHP 05:10 – BLING research background 17:30 – BLING III methodology/results 53:50 – Practical application/future directions Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/bling-iii-rapid-reaction-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    1 hr and 7 mins
  • ANNEXa-I Deep Dive: Part II

    ANNEXa-I Deep Dive: Part II
    Jun 28 2024
    ANNEXa-I Deep Dive Part II Special Guests: Scott Dietrich, PharmD, BCCCP Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS Todd Miano, PharmD, PhD, FCCM 03:13 – Safety/thrombotic findings 21:50 – Questions that remain 26:50 – Practical considerations 41:40 – P&T elevator pitch Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-ii-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    52 mins
  • ANNEXa-I Deep Dive: Part I

    ANNEXa-I Deep Dive: Part I
    Jun 28 2024
    ANNEXa-I Deep Dive Part I Special Guests: Scott Dietrich, PharmD, BCCCP Brian Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS Todd Miano, PharmD, PhD, FCCM 05:40 – Brief ANNEXa-I study overview 20:40 –Primary composite outcome 26:40 – Anti-FXa levels 30:45 – Statistics/methodology questions Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/annexai-deep-dive-part-i-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    54 mins
  • January 2024 Literature Review Series

    January 2024 Literature Review Series
    Jun 25 2024
    Literature Review Series January 2024 Special Guests: Haley Torr, PharmD Nick Tran, PharmD 06:55 – Featured Articles 32:55 – PAD-IS articles 37:10 – Cardiology articles 46:00 – Heme articles 51:40 – Potpourri articles 60:05 – Pharmacist-featured articles 67:30 – Sweet Emotion articles Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/jan-2024-lrs-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    1 hr and 16 mins
  • Trial of the Week: PROWESS-SHOCK

    Trial of the Week: PROWESS-SHOCK
    Jun 21 2024
    Trial of the Week: PROWESS-SHOCK Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita 03:30 – Background studies/Setting the scene 30:25 – PROWESS-SHOCK discussion/Where are we now Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (activated) in adults with septic shock” published in the New England Journal of Medicine in 2012. To fully understand the discussion regarding drotrecogin alfa, Paul and I review the mechanism of action and its proposed action in the treatment of sepsis. Then we review earlier studies and the controversy behind the FDA approval process. Finally, we go into detail on what Clinical Pharmacists were tasked with doing at the time based on treatment protocols or hospital restrictions. Then we dive into the Trial of the Week, discussing the study design and results. What was the mood in ICUs and Pharmacy Departments after this publication? How much did our sepsis care improve from PROWESS to PROWESS-SHOCK? What lessons did we learn with the Xigris FDA approval process? Is there a patient population that could still benefit from drotrecogin alfa treatment? Plus, trial fun facts, issues with calculating APACHE II scores, and so much more. Reference list: https://pharmacytodose.com/wp-content/uploads/2024/06/prowess-shock-trial-of-the-week-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    1 hr
  • 2023 Year-In-Review Literature Review Series

    2023 Year-In-Review Literature Review Series
    Jun 6 2024
    Literature Review Series 2023 Year-In-Review Special Guests: Jacquelyn Crawford, PharmD @jacuronium Kathleen Hartman, PharmD @HartKate8 04:30 – Neurology 11:05 – Cardiology 18:50 – Cardiac Arrest 26:30 – Pulmonary 35:00 – Sepsis 44:05 – Endocrine/Renal 52:30 – Trauma 61:05 – Infectious Diseases Reference List: https://pharmacytodose.com/wp-content/uploads/2024/06/yir-2023-lrs-references.pdf PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show more Show less
    1 hr and 15 mins